BSX vs. FMS: Boston Scientific vs. Fresenius Medical Care Stock Comparison

Company Profile

Boston Scientific (BSX) and Fresenius Medical Care (FMS) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while FMS is classified in Health Care Providers & Services.

Boston Scientific (BSX) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Boston Scientific (BSX) is heavily traded at around 19.73M shares per day, whereas Fresenius Medical Care (FMS) sees a more moderate 954.21K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Boston Scientific (BSX) at 14.12% and Fresenius Medical Care (FMS) at 7.84% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Boston Scientific (BSX) at 16.62% retains a top-quartile share of revenue as profit, ahead of Fresenius Medical Care (FMS) at 4.22%, which keeps about the industry-typical share.

Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Fresenius Medical Care (FMS) at 9.63%, which runs around its industry’s norm.

Profitability Metrics

Growth

Boston Scientific (BSX) at 19.87% is around its peer norm for revenue growth, while Fresenius Medical Care (FMS) at 1.51% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Both Boston Scientific (BSX) at 55.20% and Fresenius Medical Care (FMS) at 83.61% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.

Growth Metrics

Financial Strength

Both Boston Scientific (BSX) at 1.37 and Fresenius Medical Care (FMS) at 0.99 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Both Boston Scientific (BSX) at 0.46 and Fresenius Medical Care (FMS) at 0.79 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a yield of 6.30%, ranking against industry peers normally.

Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a payout of 50.14%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Boston Scientific (BSX) at 18.04 and Fresenius Medical Care (FMS) at 13.53 sit in the cheaper earnings-multiple quartile for P/E ratio, with the market paying less for a dollar of trailing earnings than it pays for typical peers.

Fresenius Medical Care (FMS) at 0.62 sits in the cheaper P/S ratio quartile while Boston Scientific (BSX) at 2.94 prices around its industry’s middle — FMS costs less per dollar of sales, though read it alongside growth and margins.

Fresenius Medical Care (FMS) at 0.85 sits in the lower P/B ratio quartile against book while Boston Scientific (BSX) at 2.42 is valued near its industry’s middle — FMS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics